GHK-Cu

GHK-Cu, also known as Copper Peptide GHK or glycyl-L-histidyl-L-lysine copper, is classified as an cellular senescence peptide extensively studied in laboratory research models. This tripeptide compound demonstrates significant potential in tissue remodelling and regenerative research applications. The mechanism of action involves GHK-Cu binding to copper ions, facilitating their transport into cells within research models. Studies indicate that this process activates tissue remodelling pathways by upregulating collagen synthesis and promoting wound healing responses. The peptide also modulates gene expression related to inflammation and oxidative stress, enhancing skin repair and regeneration processes in laboratory studies. Primary research effects observed in studies include enhanced wound healing, stimulated collagen production, reduced inflammation markers, improved skin elasticity measurements, and promoted follicular biology in research models. These effects make GHK-Cu tripeptide a valuable compound for cellular senescence research and tissue regeneration studies. The evidence grade is classified as B, with several small human trials suggesting that GHK-Cu can improve skin healing and reduce signs of aging in research models. However, researchers note that larger and more rigorous studies are needed to confirm these effects and establish optimal parameters for laboratory applications. Current research continues to explore the full potential of this copper peptide in various regenerative medicine applications.